Introduction
Human herpesvirus-8-associated B-cell lymphoma is a common disease entity in immunocompromised individuals, particularly in patients with chronic HIV-infection or AIDS. However, cardiac manifestations are extremely rare. 
Case presentation
In this report, we present a case of a solitary left atrial manifestation of an HHV8þ B-cell lymphoma in a 59-yearold patient presenting with B symptoms and a cardiac mass on echocardiography. Due to the high operative risk of the patient, a transcatheter/trans-septal biopsy was performed to establish the diagnosis. 1 Less frequently, extranodal manifestations can occur and only 0.5% of all NHL extranodal lymphomas have a primary cardiac localization. 2, 3 Among these, diffuse large B-cell lymphomas account for 80% of cardiac lymphomas with predominantly right atrial manifestation.
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Learning points
• Only 0.5% of all non-Hodgkin lymphomas with extranodal disease have a primary cardiac localization. Among these, diffuse large B-cell lymphomas account for 80% of cardiac lymphomas with predominantly right atrial manifestation.
• Right-sided cardiac masses are easily accessible by a transvenous approach. To avoid systemic embolization, pathologic samples from left-sided cardiac tumours are more commonly obtained by open surgery.
• Transcatheter/trans-septal biopsy for left atrial tumours represents minimally invasive alternative for patients at high risk for surgery. 
Timeline Case presentation
A 59-year-old patient presented with fever, night-sweats, and a weight-loss of 9 kg within 5 months. The patient had a 30-year history of an HIV-infection with stable disease and HIV load below detection threshold under a raltegravir and emtricitabine/tenovofir treatment regimen. Clinical examination revealed a generalized lymphadenopathy, the lungs were clear to auscultation, heart sounds notable for a normal S1, S2, no rubs, or murmurs heard. The abdomen was soft without tenderness. There was no evidence of peripheral oedema. Positron emission tomography-computer tomography (PET-CT) imaging workup revealed a generalized lymphadenopathy and splenomegaly.
As no cardiac tumour was suspected at this time point, PET-CT was performed without suppression of myocardial glucose uptake.
Blood sampling showed normochromic anaemia and blood cultures obtained during spiking fever were negative. A subsequent bone marrow biopsy and bronchoscopic biopsy of peribronchial lymph nodes indicated reactive lymphocytosis in the course of epstein barr virus (EBV) infection (polymerase chain reaction positive) without evidence of malignancy.
Due to persistent symptoms and progressive dyspnoea, transthoracic echocardiography was performed. Hereby, a left atrial mass was detected. Transoesophageal echocardiography (TOE) demonstrated attachment of the mass (approximating 4 Â 2 Â 2 cm) to the atrial wall with diastolic protrusion into the left ventricle.
Because of the unknown embolic risk, oral anticoagulation with Rivaroxaban was initiated.
To determine the nature of the cardiac lesion, cardiac magnetic resonance imaging (CMRI) was performed. Hereby, a solitary left atrial tumour with exophytic protrusion into the atrial lumen was seen, exhibiting a homogenous isointense signal in T1-and T2-weighted and post-contrast sequences, making the diagnosis of thrombus, myxoma, or fibroelastoma unlikely ( Figure 1) .
Given the size and unknown origin of the intra-cardiac mass, operative resection of the tumour was aimed for, but the patient was considered inoperable due to his increasingly poor condition. In order to obtain histopathological diagnosis to allow specific treatment, we decided to pursue a trans-septal catheter-based biopsy.
The procedure was guided by TOE using a steerable introducer (Agilis TM NXT, St. Jude Medical). After trans-septal puncture in the central fossa ovalis, multiple biopsies of the atrial mass were taken ( Figure 2A -C, Supplementary material online, Video S1) without complication. The patient was discharged 2 days after the procedure. Upon histopathological workup of the obtained samples, the diagnosis of an HHV-8 positive, diffuse large B-cell lymphoma was made ( Figure 2D) , and Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (R-CHOP) treatment regimen was initiated. This treatment resulted in a halt of tumour growth by echocardiography and eventually a size reduction that was confirmed on follow-up PET-CT scan 8 months after discharge (Figure 3) , suggesting a partial remission. Unfortunately, the PET scan revealed a new thoracic lesion (Figure 3, arrow) .
The patient-now in an increasingly poor condition-decided to avoid further radiation or chemotherapy treatment, chose a best supportive care regimen, and consequently no histopathological diagnosis of the new thoracic lesion was established. Nine months after discharge, the patient died at home from unknown cause with no post-mortem exam performed. 
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Cardiac surgery consultation considering patient at very high risk for surgery.
7 TOE-guided trans-septal catheter-based biopsy using a steerable introducer 9
Discharge of the patient. Non-Hodgkin lymphoma patients present a nodal disease, typically restricted to body cavity-based lymphomas, e.g. primary effusion lymphomas. Less frequently, extranodal manifestations can occur. 2 Only 0.5% of all NHL extranodal lymphomas have a primary cardiac localization. 3 Among these, diffuse large B-cell lymphomas account for 80% of cardiac lymphomas 4 with predominantly right atrial manifestation. 5, 6 To our knowledge, the case presented here is the first report of a primary HHV8þ B-cell lymphoma of the left atrium. Improved imaging methods, particularly CMRI and cardiac 18-Fluorodeoxyglucose ( 18 F-FDG) PET imaging under suppression of myocardial glucose uptake, have improved diagnosis of cardiac masses. [7] [8] [9] Nevertheless, histopathology is still required in many cases to initiate appropriate treatment.
While right sided cardiac masses are easily accessible by a transvenous approach, very few trans-septal biopsies of left atrial tumours have been reported. 10, 11 To avoid systemic embolization, pathological samples from left-sided cardiac tumours are more commonly obtained by open surgery. As trans-septal puncture has become a standard in routine procedures to treat arrhythmias or structural heart disease, techniques and material for this access route have improved in the past decade. Due to this development, the transcatheter/trans-septal approach for left atrial biopsy could represent a straight-forward and minimally invasive alternative for patients at high risk for a surgical procedure. Although systematic evidence will be needed to evaluate and quantify the risk of embolization with this diagnostic approach, trans-septal atrial biopsy may serve as a novel diagnostic tool in selected patients. After six cycles of R-CHOP treatment (three cycles with 50% dosage reduction) significant reduction of left atrial lymphoma dimension. New lesion in left hemithorax (indicated by the arrow). The second scan was performed after an 18-h fasting period. However, residual myocardial FDG uptake is seen, impeding the evaluation of the atrial mass.
